Key takeaways
- Dapoxetine is an on-demand treatment for diagnosed premature ejaculation, rather than a daily antidepressant treatment. Irish Priligy prescribing information.
- The clinical problem includes poor control and distress, not simply falling short of an imagined ideal duration. HPRA product information.
- Nausea, dizziness and fainting can occur. The product information advises avoiding alcohol. Priligy safety information.
- A trial found benefit in selected men also receiving erectile-dysfunction treatment, but that does not override the label’s warning against combining Priligy with PDE5 inhibitors. Combination trial, HPRA prescribing information.
When sex becomes a countdown, a promise of “lasting longer” can sound like the whole answer. In practice, feeling more in control and less distressed may matter just as much as time.
Dapoxetine, the ingredient associated with Priligy and catalogue brands such as Poxet, is worth understanding on those terms. It is not an erection medicine, and it is not a way to guarantee a particular sexual performance.
What can dapoxetine improve?
Trials assess time to ejaculation, perceived control and distress, rather than a single target duration.
The Irish Priligy authorisation is for men aged 18 to 64 who meet its diagnostic criteria for premature ejaculation. It is not intended for men without that diagnosis who simply want to delay ejaculation. The clinical assessment also considers whether the problem is longstanding or new and whether erection difficulties are involved. HPRA-authorised medicine information.
A randomised trial in 495 men with both premature ejaculation and erectile dysfunction found improvements in ejaculation time and patient-reported outcomes compared with placebo. Those men were already on stable PDE5-inhibitor treatment and were selected for the study, so the results should not be generalised to everyone considering dapoxetine. Combination trial.
How is on-demand treatment different from daily antidepressants?
Dapoxetine is designed for use around anticipated sexual activity, but “short-acting” does not mean instantly cleared or interaction-free.
Its blood concentration falls relatively quickly after the initial peak, while a slower elimination phase remains. It is misleading to say the medicine has completely left the body within a day. Nor does its short-acting profile guarantee the absence of sexual side effects. Priligy pharmacology and adverse effects.
European urology guidance also discusses topical anaesthetics, off-label antidepressants and psychosexual approaches. Treatment can address distress and communication as well as ejaculation timing. These are options to compare, not medicines to combine independently. EAU guideline.
Do not add dapoxetine to an existing antidepressant regimen because both medicines appear under “SSRIs”. Our vortioxetine article discusses sexual function in the different context of depression treatment.
| What you want to improve | What needs checking |
|---|---|
| Ejaculation control | Whether the symptoms fit premature ejaculation |
| Erection firmness | Whether erectile dysfunction needs its own assessment |
| Treatment-related sexual problems | Whether an existing medicine is contributing |
| Comfort and confidence | Whether psychosexual or relationship support could help alongside treatment |
Can dapoxetine be combined with sildenafil or tadalafil?
Do not assume a positive trial makes the combination suitable for self-treatment.
The selected-patient trial reported benefit, but adverse events were also more frequent with dapoxetine than placebo. The Irish Priligy prescribing information advises against use in men with erectile dysfunction taking PDE5 inhibitors, because of concerns about reduced tolerance to standing-related blood-pressure changes. Trial, HPRA warning.
EAU guidance discusses PDE5 inhibitors and combination treatment in selected circumstances, so guideline recommendations and individual product labels are not identical. A clinician assessing both conditions needs to account for the exact products, health history and applicable prescribing information. Neither a blanket claim that combinations never help nor encouragement to mix them yourself reflects that distinction. EAU treatment recommendations.
Which risks should be discussed before treatment?
Fainting history, heart disease and interactions are particularly important.
Other antidepressants, MAO inhibitors, tramadol and serotonergic supplements such as St John’s wort can create serious interaction risks. Alcohol increases concern about dizziness, impaired judgement and fainting. If you become light-headed, sit or lie down safely; do not drive while affected. Priligy warnings.
A newly developed sexual problem can also merit a broader assessment. Our prolactin article discusses one specific hormonal condition, not a reason for routine hormone treatment or testing in everyone with premature ejaculation.
Do and don’t
Do: Explain control, distress, erection quality and other medicines openly, and review whether treatment is helping in ways that matter to you.
Don’t: Combine dapoxetine with antidepressants or erection medicines on your own, drink alcohol with it or judge success against an arbitrary stopwatch target.